We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.25 | -1.72% | 14.25 | 1,152,228 | 11:56:50 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 14.00 | 14.50 | 14.25 | 14.00 | 14.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -11.05 | 134.53M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:25:48 | O | 17,735 | 14.15 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 24/7/2024 | 07:00 | UK RNS | Scancell Holdings Plc Update from iSCIB1+ Clinical Advisory Meeting |
| 10/7/2024 | 07:00 | UK RNS | Scancell Holdings Plc Appointment of Dr Florian Reinaud to the Board |
| 02/7/2024 | 20:03 | ALNC |  TRADING UPDATES: Creo extends contract; Belluscura raises funds |
| 02/7/2024 | 07:00 | UK RNS | Scancell Holdings Plc Extension of Convertible Loan Notes |
| 01/7/2024 | 07:00 | UK RNS | Scancell Holdings Plc Block Listing Return and Total Voting Rights |
| 21/6/2024 | 07:00 | UK RNS | Scancell Holdings Plc Change of Nominated Advisor |
| 12/6/2024 | 13:13 | ALNC | Shares in Scancell climb as strikes exclusive drug evaluation deal |
| 12/6/2024 | 07:32 | UK RNS | Scancell Holdings Plc Agreement with major biotech |
| 31/5/2024 | 07:00 | UK RNS | Scancell Holdings Plc Scancell to attend upcoming conferences |
| 30/5/2024 | 07:00 | UK RNS | Scancell Holdings Plc Update on ModiFY trial |
Scancell (SCLP) Share Charts1 Year Scancell Chart |
|
1 Month Scancell Chart |
Intraday Scancell Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/7/2024 | 23:04 | Scancell - Pot of Gold or POS? | 9,987 |
| 26/7/2024 | 12:39 | Using immunology to fight cancer. | 57,616 |
| 26/7/2024 | 12:32 | Scancell investors thread (litter free) | 459 |
| 14/6/2024 | 12:23 | Scancell for investors (inanaco free thread) | 237 |
| 01/12/2023 | 15:26 | Scancell - BS free thread | 2 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-07-26 15:25:49 | 14.15 | 17,735 | 2,509.50 | O |
| 2024-07-26 15:22:35 | 14.30 | 2,000 | 286.00 | O |
| 2024-07-26 15:10:17 | 14.36 | 7,800 | 1,120.28 | O |
| 2024-07-26 14:50:06 | 14.00 | 344 | 48.16 | O |
| 2024-07-26 14:50:06 | 14.00 | 71 | 9.94 | O |
| Top Posts |
|---|
Posted at 26/7/2024 09:20 by Scancell Daily Update Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 14.50p.Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £132,214,347. Scancell has a price to earnings ratio (PE ratio) of -11.05. This morning SCLP shares opened at 14p |
Posted at 26/7/2024 23:04 by inanaco knowlesi - 12 Jul 2023 - 15:59:53 - 4754 of 9987 Scancell - Pot of Gold or POS? - SCLPInanaco - I don't think it has failed. But one shot at goal has gone imo - modi1 as a montherapy isn't going to happen (in my opinion and based on LD comments). Shot at goal missed hence valuation lowered. As per my post - and pretty much all my posts - still think this has long term value. We don't disagree there. I would seriously challenge the 8 quid mantra (not a chance) but 75p-£1. Yep - I could possibly see 1.50 but modi1 results are a huge blow and but a real ceiling on valuation going forward. All my opinion. I also seriously doubt a CI will partner a combination drug that needs 4 injections - that is ridiculous. Remember - we turned down CI combo trial in 2015 - 8 years later here we are. Not great. The share price the last 2 days tells you that. Down 20% is just the start. As per my post yesterday single digits is coming and possibly testing new lows. Risk up, timelines increased, more potential jam tomorrow - market says no thanks. -------------------- ""I also seriously doubt a CI will partner a combination drug that needs 4 injections - that is ridiculous."" Merck has partnered Moderna ... and do you know how many times you have to intravenous drip a checkpoint ? you can be on it for two years !! so lets get this right .... shares moves up from single digits and you now need it back down because the Knowlesi bazooka got damp ..... everyone will remember the knowlesi Bazooka ... you can read my posts on the lse History his have been deleted also I dont recall Lindy turning down any trial ? do u have a link ? |
Posted at 26/7/2024 15:43 by inanaco so your problem is simpleHVO 30p SCLP 14p if after one year the share price is highest wins if you won't bet why you holding HVO ? |
Posted at 26/7/2024 08:50 by chilltime Just putting it out there as some don’t understand uncrossing trades and share prices jumping in the auction close due to UTsEG it was mid price 14p, the UT in the auction crossed at 14.5p, giving a closing mid price of 14.5p which was false as a mid price in reality. Bid offer opened as per 16.30 yesterday 13.5 to 14.5. I see the question on various shares hence the comments, sometimes it’s the reverse and shares appear to open, up in price. |
Posted at 22/7/2024 17:47 by chilltime InanThose 500k sells that you call them are buys, the share price direction tells you that. It’s not necessarily someone supplying a 500k lump. EG X puts in an order for 500k, the broker fills the order by whatever means including multiple smaller buys available in the market. Typically the relevant broker sits on the bid. Once the order is filled whether it took hours or days, it gets reported to the market, typically mid price and in the unknown column. It’s perfectly legitimate under the rules for orders over the typical market size to be reported once they are complete. There is no fee for each buy hence you’ll see multiple apparently very small trades, it’s just a collection system for anything hitting the price. If selling 1 mill, 2 mill etc to a buyer that approached them that trade would appear as that amount once it’s completed, often double printed, shares in shares out, sometimes triple. As the price is rising it suggests buying in the market, order in, electronically sweeping up sells. Others buy (private investors) in rising prices. It all depends how many the buyer wants and what price they are willing to pay for them. It could be 10 mill then stop or the start of a large stake with plans to acquire Scancell. It’s not unreasonable to speculate a pharma is buying, given the patent cliffs for those in Melonoma sector with Scib so far blowing their treatments out of the water. Scancell could in theory, steal a $1.5 bill market right from under their noses. If Scancell do that, they potentially have the cash firepower to enhance patent cliff treatments with their platforms to become the standard of care. Redmile and Vulpes saw this coming long before the rest. If the data hits the mark (it should) other big funds wanting larger chunks are already waiting in the wings. Lindy mentioned that point in an interview. Interesting times ahead for investors and cancer sufferers. |
Posted at 19/6/2024 15:41 by 2tyke Sci102,The traders which control price probably wouldn't even watch a video about the company progress. Why would they when it makes zilch difference. In the market....PRICE IS EVERYTHING. You think it isn't at your own peril and loss. Big investors ? Irrelevant to a share price They matter to the company..not the share price The huge profits are with real assets like Bitcoin. Trader sentiment is sky-high. You'll find little investors like inane in stocks like this . Sitting in a car park counting pennies...lol |
Posted at 14/6/2024 06:47 by chilltime Just popped on to have a look, 844 posts missed, 84.4% which appear to be nonsense. Please feel free to go through the last 844 to clarify my percentage findingsSci You appear to be an AIM trader, hoping for an AIM type company/CEO here. I too was frustrated by the lack of updates, probably due to being conditioned by the majority of small caps who pump out regular news. However, I was quick to learn on Scancell, that Lindy is a dedicated scientist determined to progress treatment of csncer, NOT a typical AIM CEO focussed on retail investors hunger for news. News to create volume and share price movements. Scancell does not have a retail herd following as a result of the lack of flag waving. Others do have a retail crowd following them, the volume and share price moves are regular, usually due to regular pump news by over-exuberant CEOs. Near all have been decimated, many bust. Lindy has said she will shout when she has something to shout about. In AIM terms, for AIM conditioned investors an 85% response rate should be plastered all over social media with 1000’s of retail piling in and a market cap of £600m plus now. The thread would be full of nutters calling £50 per share etc. They do that on Scancell fraction of what Scancell are actually achieving. If you are experienced in the stock market as you claim, then you should know that. |
Posted at 13/6/2024 09:29 by 2tyke None of this actually matters Sci102.The more one understands about a company...the less they will understand where the share price is heading. That's why broker views on price are irrelevant...they follow the company...not the price. The group of people who understand the least about the share price direction ? The directors of the company. If you see a director of a company buy....follow at your peril ! |
Posted at 01/6/2024 19:02 by markingtime Didn't Vulpes describe the valuation as "derisory" a year or so ago, when the share price was double the present price and the trials data had barely started to emerge?Were they wrong?Surely that language implied their estimation was for the share price to be 30p+ back then? |
Posted at 21/5/2024 09:01 by ruckrover Ivy,Thanks for that. I've given up looking for RNSs so I didn't spot it. We had a similar no risk share purchase scheme when I worked for one of the big banks. All your share money was put in an account effectively buying options at a fixed price. If the share price went up you could take profits. If the share price went down your investment fund remained intact. They even paid you interest on it. If only we got that from Scancell - 12 years interest compounded would be worth a pretty penny today! |
Posted at 03/5/2024 21:20 by 2tyke Nope the share price is NOT governed by the probability of success or the probability of failure of products.It IS governed by herding traders either trying to make money...or limit losses. The long term investors in love with the company do not play a part in share price movement. They have already acted, usually at the wrong time due to incorrect premise, and are literally tossed around by the price waves. So what do they do ? Complain about the market not understanding their incorrect premise (lol)....comfort eachother that they all have the incorrect premise and so all will be ok in the end (lol)....pray for a takeover ( which is a desperate and very poor reason to hold any stock position). |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
